Autopsy report · NCT01613482

TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention

“Lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 5 months after it had already started.
• Ran for about 4 years before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Centre Oscar Lambret

Sponsor type

University, hospital or other

Conditions

Breast Cancer; Metastasis; Sur-expressing Her2-neu

Interventions

cerebral prophylactic radiation; Trastuzumab; Other chemotherapy in association with Trastuzumab

Participants

13

Sites

26

Countries

France

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.